Abstract
BackgroundThe course of rheumatoid arthritis (RA) varies considerably among different patients. To optimise management, individual’s outcomes need to be recognised as early as possible. Novel biological markers specifically reflecting the...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
